CrossBay Medical news

CrossBay Medical receives FDA Clearance for CrossGlide™ ETS Plus for frictionless, office-based endometrial biopsy procedures focused on patient comfort. Similar to the CrossGlide ETS, Endometrial Tissue Sampler (which received FDA clearance this summer), the ETS Plus also enables medical providers to perform a frictionless, office-based endometrial biopsy procedure gently, effortlessly and without a tenaculum. This new ETS Plus device is also indicated for use for sonohysterography for

CrossBay Medical has received FDA clearance for its CrossGlide Endometrial Tissue Sampler. The CrossGlide™ ETS, the third product to utilize the frictionless CrossGlide technology platform, enables medical providers to perform an office-based endometrial biopsy procedure gently, effortlessly and without a tenaculum. The product is designed for simpler access to the uterine cavity than currently available modalities.

CrossBay Medical, Inc., a health technology company focused on humanizing the delivery of women’s healthcare, has announced the launch of a new website, introducing its CrossGlide™ technology platform. The site, www.cro

Hologic, Inc. (Nasdaq: HOLX) has launched the Definity™ cervical dilator, a major advancement for gynecological procedures that uses SureAccess™ balloon technology to gently and effortlessly access uterine cavities without a tenaculum, lessening patient discomfort and reducing risk of perforation during dilation.

CrossBay Medical, Inc., today announced that it has received clearance to commercialize its product, the Endometrial Tissue Sampler using CrossGlide™ technology, in Europe by obtaining its CE Mark. The use of this technology allows a novel way to obtain an office-based endometrial biopsy, a very common tissue-sampling procedure performed in women’s health offices worldwide. The ETS is the third product using the frictionless CrossGlide™ technology to receive marketing author